Regulation of artificial intelligence (AI) in Asia Pacific remains nascent, mostly governed by existing regulatory frameworks designed for other technologies and products. It’s a work in progress. AI techniques – machine...more
Recently, the National Medical Products Administration (NMPA) issued the draft version of 'Implementation Measures for Drug Trial Data Protection (hereinafter referred to as the 'Draft for Comments'), aiming to clarify the...more
4/1/2025
/ Biologics ,
China ,
Clinical Trials ,
Data Protection ,
Drug Pricing ,
Generic Drugs ,
New Regulations ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Regulatory Requirements